BioVie Inc. (BIVI)
NASDAQ·Healthcare·Biotechnology
$1.57
-1.26%
Mkt Cap $10.48M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 6, 2026 | — | — | — | -$0.81 | -$0.77 | +4.94% | — | — |
| Q4 2025 Nov 10, 2025 | — | — | — | -$0.79 | -$0.98 | -24.05% | — | — |
| Q3 2025 Aug 15, 2025 | — | — | — | -$4.40 | -$0.24 | +94.63% | — | — |
| Q2 2025 May 12, 2025 | — | — | — | -$3.20 | -$1.50 | +53.13% | — | — |
| Q1 2025 Feb 11, 2025 | — | — | — | -$16.00 | -$4.60 | +71.25% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$16.00 | -$7.00 | +56.25% | — | — |
| Q3 2024 Sep 30, 2024 | — | — | — | -$15.00 | -$66.00 | -340.00% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$0.33 | -$20.00 | -5960.61% | — | — |
| Q1 2024 Feb 12, 2024 | — | — | — | -$32.00 | -$22.00 | +31.25% | — | — |
| Q4 2023 Nov 8, 2023 | — | — | — | -$0.31 | -$29.00 | -9254.84% | — | — |
| Q3 2023 Aug 16, 2023 | — | — | — | -$37.00 | -$23.00 | +37.84% | — | — |
| Q2 2023 May 12, 2023 | — | — | — | -$0.35 | -$43.00 | -12185.71% | — | — |
| Q1 2023 Feb 10, 2023 | — | — | — | -$0.25 | -$50.00 | -19900.00% | — | — |
| Q4 2022 Nov 4, 2022 | — | — | — | -$0.28 | -$38.00 | -13471.43% | — | — |
| Q3 2022 Sep 27, 2022 | — | — | — | -$0.37 | -$33.00 | -8818.92% | — | — |
| Q2 2022 May 11, 2022 | — | — | — | -$0.42 | -$0.28 | +33.33% | — | — |
| Q1 2022 Feb 8, 2022 | — | — | — | -$0.31 | -$0.28 | +9.68% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | — | -$23.36 | — | — | — |
| Q3 2021 Aug 30, 2021 | — | — | — | -$2.32 | -$10.18 | -338.79% | — | — |
| Q2 2021 May 10, 2021 | — | — | — | — | -$21.50 | — | — | — |